Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00311909 · ClinicalTrials.gov registry record · Phase 2
Thalamic Deep Brain Stimulation for Tourette Syndrome
A Phase 2 study, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 5
- Enrollment target
NCT00311909 is a Phase 2 study that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 5 participants.
The verdict
NCT00311909, a Phase 2 study, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether deep brain stimulation is effective at reducing tic frequency and severity in adults with Tourette syndrome.
Interventions
- DEVICE Thalamic deep brain stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2005-06 |
| Est. Completion | 2006-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00311909
The ClinicalTrials.gov registry entry for NCT00311909 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Thalamic deep brain stimulation is the first listed.
NCT00311909 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00311909 about?
NCT00311909 is a clinical study titled "Thalamic Deep Brain Stimulation for Tourette Syndrome". The purpose of this study is to determine whether deep brain stimulation is effective at reducing tic frequency and severity in adults with Tourette syndrome.
What is the current status of trial NCT00311909?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 5 participants. The study started on 2005-06. Estimated completion is 2006-04.
What interventions are being tested in trial NCT00311909?
The interventions under investigation include: Thalamic deep brain stimulation (DEVICE).
Who is sponsoring clinical trial NCT00311909?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.